BLU BELLUS Health Inc.

BELLUS Health, Inc. is a biopharmaceutical development company, which engages in the research and development of products that provide health solutions and address critical unmet medical needs. Its products include BLU-5937, KIACTA, AMO-01, and ALZ-801. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.

Note: This is not a U.S. company, but they cross-list their shares on a U.S. stock exchange - see the related symbol CT:BLU.

$10.39  -0.37 (-3.44%)
As of 10/05/2022 15:59:59 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Canada
Country of incorporation:  
IPO date:  10/26/2000
Outstanding shares:  125,792,916
Average volume:  587,055
Market cap:   $1,324,599,405
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      BJXPS33
Valuation   (See tab for details)
PE ratio:   -19.38
PB ratio:   4.11
PS ratio:   0.00
Return on equity:   -24.96%
Net income %:   -436,406.25%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy